2019年冠状病毒病(COVID-19)
活力
分离(微生物学)
软件可移植性
风险分析(工程)
严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)
政府(语言学)
冠状病毒
检测点注意事项
业务
传染病(医学专业)
疾病
重症监护医学
计算机科学
医学
免疫学
病理
生物
程序设计语言
哲学
微生物学
遗传学
语言学
作者
Muhammad Asif,Yun Xu,Fei Xiao,Yimin Sun
标识
DOI:10.1016/j.cej.2021.130189
摘要
Coronavirus diseases-2019 (COVID-19) is becoming increasing serious and major threat to public health concerns. As a matter of fact, timely testing enhances the life-saving judgments on treatment and isolation of COVID-19 infected individuals at possible earliest stage which ultimately suppresses spread of infectious diseases. Many government and private research institutes and manufacturing companies are striving to develop reliable tests for prompt quantification of SARS-CoV-2. In this review, we summarize existing diagnostic methods as manual laboratory-based nucleic acid assays for COVID-19 and their limitations. Moreover, vitality of rapid and point of care serological tests together with emerging biosensing technologies has been discussed in details. Point of care tests with characteristics of rapidity, accurateness, portability, low cost and requiring non-specific devices possess great suitability in COVID-19 diagnosis and detection. Besides, this review also sheds light on several preventive measures to track and manage disease spread in current and future outbreaks of diseases.
科研通智能强力驱动
Strongly Powered by AbleSci AI